AN2 Therapeutics (ANTX) Other Accumulated Expenses (2021 - 2026)
AN2 Therapeutics (ANTX) recorded Other Accumulated Expenses of $776,000 in Q2 2026, up 8.2% from $717,000 a year earlier and up 36.9% from the prior quarter.
Powered by 
Analysis
AN2 Therapeutics (ANTX) Other Accumulated Expenses (2021 - 2026) Analysis & Trends
At the end of FY2025, AN2 Therapeutics reported Other Accumulated Expenses of $1.23 million, up 55.4% from FY2024.
- Annual Other Accumulated Expenses has increased for four straight years, with a four-year compound annual growth rate of 134.0% (FY2021 to FY2025).
- Across earlier years, Other Accumulated Expenses came in at $791,000 in FY2024 (+18.8%), $666,000 in FY2023 (+445.9%), $122,000 in FY2022 (+197.6%) and $41,000 in FY2021.
- Quarterly Other Accumulated Expenses has ranged from $9,000 in Q2 2022 to $1.28 million in Q3 2024 over the past five years.
- On a year-over-year basis, Other Accumulated Expenses has increased for three consecutive quarters, with growth averaging 15.6% over the last eight quarters.
- Peak year-over-year performance for Other Accumulated Expenses in the last five years was growth of 744.7% in Q1 2024, against a decline of 85.6% in Q3 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $567,000 (Q1 2026), $1.23 million (Q4 2025) and $183,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | AN2 Therapeutics | 207.32 Mn | 207.32 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 776,000.00 |
| Mar 31, 2026 | 567,000.00 |
| Dec 31, 2025 | 1.23 Mn |
| Sep 30, 2025 | 183,000.00 |
| Jun 30, 2025 | 717,000.00 |
| Mar 31, 2025 | 369,000.00 |
| Dec 31, 2024 | 791,000.00 |
| Sep 30, 2024 | 1.28 Mn |
| Jun 30, 2024 | 559,000.00 |
| Mar 31, 2024 | 321,000.00 |
| Dec 31, 2023 | 666,000.00 |
| Sep 30, 2023 | 973,000.00 |
| Mar 31, 2023 | 38,000.00 |
| Dec 31, 2022 | 122,000.00 |
| Jun 30, 2022 | 9,000.00 |
| Mar 31, 2022 | 33,000.00 |
| Dec 31, 2021 | 41,000.00 |
API Access
AN2 Therapeutics Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=ANTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "ANTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=ANTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();